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Abstract
Background: Early diagnosis of pulmonary hypertension (PH) can potentially improve survival and quality of life.
Detecting PH using echocardiography is often insensitive in subjects with lung fibrosis or hyperinflation. Right
heart catheterization (RHC) for the diagnosis of PH adds risk and expense due to its invasive nature. Pre-defined
measurements utilizing computed tomography (CT) of the chest may be an alternative non-invasive method of
detecting PH.
Methods: This study retrospectively reviewed 101 acutely hospitalized inpatients with heterogeneous diagnoses,
who consecutively underwent CT chest and RHC during the same admission. Two separate teams, each consisting
of a radiologist and pulmonologist, blinded to clinical and RHC data, individually reviewed the chest CT’s.
Results: Multiple regression analyses controlling for age, sex, ascending aortic diameter, body surface area, thoracic
diameter and pulmonary wedge pressure showed that a main pulmonary artery (PA) diameter ≥29 mm (odds ratio
(OR) = 4.8), right descending PA diameter ≥19 mm (OR = 7.0), true right descending PA diameter ≥ 16 mm (OR =
4.1), true left descending PA diameter ≥ 21 mm (OR = 15.5), right ventricular (RV) free wall ≥ 6 mm (OR = 30.5),
RV wall/left ventricular (LV) wall ratio ≥0.32 (OR = 8.8), RV/LV lumen ratio ≥1.28 (OR = 28.8), main PA/ascending
aorta ratio ≥0.84 (OR = 6.0) and main PA/descending aorta ratio ≥ 1.29 (OR = 5.7) were significant predictors of PH
in this population of hospitalized patients.
Conclusion: This combination of easily measured CT-based metrics may, upon confirmatory studies, aid in the
non-invasive detection of PH and hence in the determination of RHC candidacy in acutely hospitalized patients.
Background
Pulmonary hypertension (PH) is characterized by the
presence of increased pulmonary vascular resistance
caused by a combination of vasoconstriction, vascular
remodeling, and thrombosis. Unfortunately, it can be
potentially life-threatening as progressive right ventricu-
lar dilatation and hypertrophy may lead to heart failure
within a few years [1,2]. As the treatment of PH has
advanced dramatically over the past decade [3], early
diagnosis may be key to its optimal treatment. While
right heart catheterization (RHC) remains the “gold
standard” for the measurement of pulmonary arterial
pressure (PAP) [4], its invasive nature confers both risk
and expense, and hence can delay diagnosis. Echocardio-
graphy as a noninvasive means of estimating PAP is lim-
ited in patients with obesity, lung hyperinflation and
pulmonary fibrosis [5-7]. Magnetic resonance imaging
methods have unfortunately also not been shown to
accurately estimate PAP [8].
Other noninvasive PH screening tools include a predic-
tion formula for estimating mean PAP using standard
pulmonary function measurements in patients with idio-
pathic pulmonary fibrosis [9]. In addition, computed
tomography (CT)-determined main pulmonary artery dia-
meter has been shown to have excellent diagnostic value
in the detection of PH in patients with parenchymal lung
disease [10]. Such noninvasive approaches towards the
detection of PH can reduce patient risk and expense, and
may allow earlier patient screening towards a confirmatory
RHC [11] or perhaps even obviate its necessity. This study
retrospectively reviewed the records of inpatients who had
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set of CT chest-based metrics was then measured, and the
relationship of these metrics to RHC-demonstrated PH
was assessed.
Methods
Patients
The medical records of 101 hospitalized adult patients
who consecutively underwent chest CT with or without
contrast and a resting RHC during the same hospitaliza-
tion were retrospectively reviewed. These patients had
been admitted to this tertiary care teaching institution
between January 2006 and July 2006. Approval for this
review was obtained from the University of California,
Davis Institutional Review Board with waiver of consent.
Measurements
Non-ECG-gated CT scans of the chest were performed
using GE Lightspeed 16 scanners (GE Medical Systems;
Milwaukee, Wisconsin). Our standard reconstruction
protocol utilized helical technique, 5 mm slice every
5 mm with 1.25 mm every 1.25 mm reconstruction as
well. The lung windows were also reconstructed with a
“bone algorithm” and the soft tissue windows were
reconstructed with a standard soft tissue smoothing
algorithm. Standard lung windows (Width 1850, Level
-740) on bone reconstruction algorithms and standard
soft tissue windows (Width 400, Level 80) were used.
Two separate teams, each consisting of a radiologist
and a pulmonologist, blinded to the clinical and hemo-
dynamic data, independently reviewed the chest CT’s.
Pre-defined radiographic metrics corresponding to pos-
sible predictors of PH and to potential indicators of
body habitus (to standardize predictors of PH) were
measured by each team member and then averaged
(Table 1).
Cardiac catheterization was performed at rest for clini-
cal indications. Hemodynamic measurements, including
mean pulmonary arterial pressure (mPAP), pulmonary
wedge pressure (PWP), patient diagnoses and demo-
graphics (sex, age, height, and weight) were recorded.
Body surface area (BSA) was calculated using the for-
mula BSA = (W
0.425 ×H
0.725) × 0.007184, and body
mass index (BMI) was calculated using the formula BMI
= weight (kg)/(height (cm))
2.
PH was defined as a resting mPAP of 25 mmHg or
greater; “no-PH” was defined as mPAP <25 mmHg.
Statistical Analyses
Summary statistics are reported as mean ± standard
deviation (median; range). A two-sided Wilcoxon rank-
sum test was used to compare each of the quantitative
hypothesized predictors of PH and various demographics
between the PH and no-PH groups. A two-sided Fisher’s
exact test was used to compare gender, obesity (BMI
≥30), and proportion of mechanical ventilation between
the PH and no-PH groups. Statistical analyses involving
the RV wall, RV lumen, LV wall, LV lumen, or interven-
tricular septum were performed using only data derived
from CT’s that were contrast-enhanced.
Simple logistic regression was used to study the rela-
tionship between each hypothesized predictor of PH and
the outcome PH vs. no-PH. The optimal cutoff point or
upper limit of normal (ULN) for the quantitative
hypothesized predictor of PH was determined using
receiver operating characteristic (ROC) analysis, where
t h eU L Nw a sd e e m e dt ob et h ev a l u et h a ty i e l d e dt h e
best trade off between sensitivity and specificity for each
PH predictor. Multiple logistic regression was used to
assess the relationship between each of the dichotomous
hypothesized predictors of PH (i.e. variables dichoto-
mized at the ULN cutoff) and the outcome PH vs. no-PH
in order to control for sex, ascending aorta diameter
(AA), BSA, thoracic diameter (TD), and pulmonary
wedge pressure (PWP) >15. A p-value ≤ 0.05 was consid-
ered statistically significant. Statistical analyses were per-
formed with SAS v 9.2 (SAS Institute Inc., Cary, NC,
USA).
Results
101 consecutive hospitalized patients (46 women,
55 men) who underwent both CT chest and RHC were
included. Their mean age was 61.4 ± 15.6 years (median =
60; range 23 to 91 years). Fifty-three patients had PH.
Fifty-seven percent of patients with PH, and 52% of the
no-PH patients were male. The underlying patient primary
diagnoses reflect the reason for hospitalization, and were
heterogeneous (Table 2).
The RHC’s and chest CT’sw e r ep e r f o r m e dam e a no f
3 days apart (median = 1 day, range = 0-16 days); 46%
of RHC’s were performed on the same day as the chest
CT’s, and most within 2 days (60%). A majority of CT’s
were contrast-enhanced (36/48 in the no-PH group and
41/53 in the PH group). Overall, 43% (43/101) of
patients had an elevated PWP (>15 mmHg), and most
were in the PH group (40/53 = 75%).
There was no significant difference in age, height, or
sex between the PH and no-PH groups. However, PH
patients had a significantly higher mean weight, BSA,
and BMI than no-PH patients (Table 3). 41% of PH
patients were obese (BMI≥30) compared to 18% of no-
PH patients (p = 0.0175).
A comparison of the predictors of PH revealed signifi-
cantly higher measurements of PA, RDPA, true RDPA,
and hilar diameters in the PH group. The RV free wall
thickness, RV wall/LV wall ratio, hilar diameter, and
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this group (Table 4). Inter-observer variability in mea-
surements within each team was less than 5%.
Relationship of hypothesized predictors of PH to the
dichotomous outcome PH vs. no-PH
The seven significant predictors of PH in Table 4 were
also found to be significantly correlated to the outcome
(PH vs. no-PH) when using logistic regression. An OR and
ULN for each predictor of PH was determined from these
regression analyses. The optimal cutoff point or ULN was
determined by the ROC analysis to be the value that
yielded the best tradeoff between sensitivity and specificity
for each PH quantitative predictor (Table 5).
Controlling for body size, age, sex and PWP
Each dichotomous CT-derived predictor of PH (e.g. PA
diameter ≥ 29 mm) and potential confounders (age, sex,
AA, BSA, thoracic diameter, and PWP category (>15 or
≤ 15 mmHg)) were regressed to the outcome, PH vs.
no-PH, using multiple logistic regression models. In
addition to the parameters in Table 5, two additional
predictors of PH (interventricular (IV) septum bowing
into LV and main PA/AA ratio > 1) were included in
these analyses. Several predictors of PH were found to
be statistically significant when controlling for age, sex,
PWP, and indicators of body size (Table 6). Diagram-
matic representations of the significant predictors of PH
from Table 6 are represented in Figure 1.
Discussion
A National Institutes of Health Registry found that the
mean time from onset of symptoms (dyspnea 60%, fati-
gue 19%, syncope 8%, and chest pain 7%) to correct
diagnosis of PH was 2 years [12]. Early diagnosis is key
to effective treatment and potential prevention of
further vascular remodeling. When ineffectively treated,
the median survival of patients with idiopathic PH is
Table 1 Radiographic metrics
Hypothesized predictors of
PH
How measured
Main pulmonary artery
diameter (PA)
Widest lumen at or near level of
PA bifurcation *
Right pulmonary artery
diameter (RPA)
Widest lumen caudal to
ascending aorta
Left pulmonary artery
diameter (LPA)
Widest lumen
Right descending
pulmonary artery (RDPA)
Distance from lateral wall of right
bronchus intermedius to lateral
wall of RDPA (equivalent to the
RDPA measurement on a chest x-
ray)
True right descending
pulmonary artery (true
RDPA)
RDPA lumen diameter only *
True left descending
pulmonary artery (true
LDPA)
Lumen diameter distal to left
upper lobe bronchus takeoff
Right ventricular free wall
(RV wall)
Mid-ventricle *
Right ventricular lumen
diameter (RV lumen)
Mid-ventricle *
Left ventricular free wall
(LV wall)
Mid-ventricle *
Left ventricular lumen
diameter (LV lumen)
Mid-ventricle *
IV septum bowing into LV Yes or no
Left apical artery to
corresponding bronchus
ratio
Most apical bronchovascular pair
Hilar diameter (HD) At level of right middle lobe
bronchus takeoff
Hilar/Thoracic ratio HD/Inner thoracic diameter (TD)
measured at same level as HD
Landmarks used to standardize predictors of PH
Ascending aorta diameter
(AA)
Widest diameter at the level of
the PA measurement *
Descending aorta
diameter (DA)
At same level as AA *
* Also see Figure 1.
Table 2 Patient primary diagnoses
N
Coronary arterial disease 27
Congestive heart failure 22
Valvular disease 12
Pulmonary embolism 5
Cardiac arrhythmia 4
Pulmonary infection 4
Aortic aneurysm or dissection 3
Idiopathic PH 3
Interstitial lung disease 3
ARDS 2
Cardiac tamponade 2
COPD 2
Obstructive sleep apnea 2
Other * 10
*Other includes: cancer, anorexigen drug use, cerebrovascular accident, end-
stage renal disease, hepatopulmonary syndrome, kyphoscoliosis, prior history
of lung transplant, malignant hypertension, scleroderma, and trauma.
Table 3 Patient demographics
PH mean
±S D
No-PH mean
±S D
P
Age (yrs) 59.5 ± 15.4 63.5 ± 15.8 0.1948
Sex (% men) 56.6 52.1 0.6923
Height (cm) 169.8 ± 10.9 167.4 ± 10.8 0.3395
Weight (kg) 85.4 ± 22.1 71.7 ± 18.5 0.0029
BSA 1.9 ± 0.3 1.8 ± 0.3 0.0085
BMI 29.6 ± 7.1 25.3 ± 4.9 0.0024
Mechanical ventilation (%) 15.1 8.3 0.3650
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treatment options have evolved to improve both survival
and quality of life [14]. This retrospective analysis sug-
gests that CT-based metrics can help detect PH, poten-
tially enabling earlier treatment.
Although no significant differences in age, height or
gender were found between PH and no-PH patients in
this study, patients in the PH group demonstrated sig-
nificantly greater body weight, BMI and BSA. There
were significantly more obese patients in the PH group
(41%) compared to the no-PH group (18%). Neverthe-
less, most patients in both groups were not obese. The
presence of obesity, though, may contribute to PH, as
Hague et al [15] found pulmonary hypertensive changes
in 72% of obese subjects, a statistically higher proportion
than when compared to the control group (p < 0.001).
Despite the heterogeneity of the primary diagnoses of
patients in this study, the commonest diagnoses of cor-
onary arterial disease (CAD) and congestive heart failure
(CHF) were approximately equal in preponderance in
both the PH group and the no-PH group (47% vs. 50%,
respectively). A majority of patients (76%) demonstrated
an elevated PWP in the PH group, compared to 6% in
the no-PH group. This may be due in part to the higher
rate of obesity in the PH group, and possible develop-
ment of obesity cardiomyopathy, in the absence of other
risk factors such as CAD [16].
The current study not only confirmed a significant dif-
ference in the PA diameter between PH and no-PH
patients, but also showed significant differences in mea-
surement of the RDPA, True RDPA, RV free wall thick-
ness, RV Wall/LV Wall ratio, Hilar Diameter, and Main
PA/AA ratio (Table 4). These pre-defined CT-based
parameters had been previously selected at least in part
on the basis of the existing published literature [17-20],
modified and augmented using straightforward to
Table 4 Comparison of hypothesized predictors of PH in
the PH and no-PH groups
PH mean
±S D
No-PH mean
±S D
P
Main PA diameter (mm) 32.2 ± 5.3 29.0 ± 3.9 0.0021
Left PA diameter (mm) 24.2 ± 4.6 22.9 ± 3.2 0.1225
Right PA diameter (mm) 24.0 ± 4.3 23.4 ± 3.7 0.4618
RDPA diameter (mm) 19.4 ± 4.4 17.0 ± 2.6 0.0072
True RDPA diameter (mm) 15.3 ± 3.7 13.4 ± 2.4 0.0027
True LDPA diameter (mm) 19.4 ± 3.8 18.1 ± 3.4 0.0509
RV free wall thickness (mm) 5.4 ± 2.4 4.0 ± 1.2 0.0023
RV lumen diameter (mm) 36.9 ± 10.1 35.3 ± 7.9 0.4293
LV free wall (mm) 11.6 ± 3.6 11.1 ± 3.3 0.4820
LV lumen (mm) 44.0 ± 15.5 42.9 ± 9.5 0.9942
Hilar diameter (mm) 127.1 ± 13.7 118.2 ± 12.0 0.0018
RV wall/LV wall ratio 0.51 ± 0.25 0.38 ± 0.14 0.0214
RV lumen/LV lumen ratio 1.02 ± 0.85 0.85 ± 0.26 0.9796
L apical artery/bronchus ratio 1.33 ± 0.43 1.27 ± 0.35 0.6023
Hilar/thoracic ratio 0.51 ± 0.04 0.49 ± 0.04 0.0687
Main PA/AA ratio 0.97 ± 0.2 0.86 ± 0.13 0.0014
Main PA/DA ratio 1.24 ± 0.27 1.15 ± 0.17 0.2023
PH % no-PH %
IV septum bowed into LV 16.7 2.7 0.0608
See table 1 for definitions of radiographic metrics.
Table 5 Simple logistic regression of hypothesized predictors of PH to outcome (PH vs. no-PH)
P OR Lower
95% CI
Upper
95% CI
ROC AUC Sensitivity (%) Specificity (%) Upper limit of
normal (ULN) cutoff
Main PA diameter (mm) 0.0020 1.2 1.1 1.3 0.68 67.9 56.3 29 mm
Left PA diameter (mm) 0.1158 1.1 1.0 1.2 0.59 47.2 62.5 24 mm
Right PA diameter (mm) 0.4187 1.0 0.9 1.1 0.54 37.7 64.6 25 mm
RDPA diameter (mm) 0.0031 1.2 1.1 1.4 0.66 43.4 79.2 19 mm
True RDPA diameter (mm) 0.0053 1.2 1.1 1.4 0.67 32.1 83.3 16 mm
True LDPA diameter (mm) 0.0814 1.1 1.0 1.2 0.61 32.1 77.1 21 mm
RV Free Wall thickness (mm) 0.0070 1.5 1.1 2.1 0.69 21.4 91.9 6 mm
RV Lumen diameter (mm) 0.4248 1.0 1.0 1.1 0.55 66.7 18.9 30 mm
LV Free Wall (mm) 0.5105 1.0 0.9 1.2 0.55 9.5 78.4 15 mm
LV Lumen (mm) 0.7136 1.0 1.0 1.0 0.50 0.0 83.3 57 mm
Hilar diameter (mm) 0.0017 1.1 1.0 1.1 0.68 54.7 68.8 124 mm
RV wall/LV wall ratio 0.0152 22.8 1.8 283.4 0.64 61.9 64.9 0.32
RV lumen/LV lumen ratio 0.2942 1.8 0.6 5.3 0.50 19.0 94.4 1.28
L apical artery/broncus ratio 0.4379 1.5 0.5 4.2 0.53 11.3 87.5 1.75
Hilar/thoracic ratio 0.0785 >5000 0.4 >5000 0.61 35.8 79.2 0.52
Main PA/AA ratio 0.0035 58.7 3.8 900.7 0.68 79.2 50.0 0.84
Main PA/DA ratio 0.0626 6.7 0.9 50.3 0.57 30.2 83.3 1.29
See table 1 for definitions of radiographic metrics.
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P OR AUC Sensitivity (%) Specificity (%)
Main PA diameter ≥29 mm 0.0196 4.8 0.93 77.4 89.6
Left PA diameter ≥24 mm 0.2160 2.6 0.92 77.4 87.5
Right PA diameter ≥25 mm 0.4461 1.9 0.91 73.6 93.8
RDPA diameter ≥19 mm 0.0059 7.0 0.93 83.0 85.4
True RDPA diameter ≥16 mm 0.0487 4.1 0.92 83.0 87.5
True LDPA diameter ≥21 mm 0.0075 15.5 0.93 79.2 91.7
RV free wall ≥6 mm 0.0303 30.5 0.95 81.0 91.9
RV lumen ≥30 mm 0.0915 5.8 0.95 92.9 73.0
LV free wall ≥15 mm 0.1607 5.2 0.95 85.7 83.8
LV lumen ≥57 mm 0.3945 3.0 0.94 76.2 88.9
Hilar diameter ≥124 mm 0.2968 2.2 0.92 81.1 75.0
RV wall/LV wall ratio ≥0.32 0.0141 8.8 0.96 78.6 83.8
RV lumen/LV lumen ratio ≥1.28 0.0196 28.8 0.95 85.7 86.1
L apical artery/bronchus ratio ≥1.75 0.2851 3.5 0.92 75.5 87.5
Hilar/thoracic ratio ≥0.52 0.0757 3.7 0.92 75.5 87.5
Main PA/AA ratio ≥0.84 0.0208 6.0 0.93 73.6 91.7
Main PA/DA ratio ≥1.29 0.0269 5.7 0.93 77.4 89.6
IV septum bowing into LV (yes or no) 0.1053 11.6 0.95 81.0 89.2
Main PA/AA ratio >1 0.0085 9.1 0.93 86.8 79.2
Regression of the outcome variable (PH vs. no-PH) to the predictors:
ULN for each hypothesized predictor of PH, age, sex, ascending aorta diameter (AA), BSA, thoracic diameter (TD), and pulmonary wedge pressure (PWP)
>15 mmHg.
Note: one logistic regression model was created for each hypothesized predictor of PAH. For example, the analysis in the first row above included the predictors:
Main PA diameter ≥29, age, sex, AA, BSA, TD, and PWP >15. See table 1 for definitions of radiographic metrics.
Figure 1 Radiographic measurements. The radiometric measurements used to derive the predictors of PH that were found to be significant in
Table 6 included: main PA (a), AA (b), DA (c), RV free wall (d), RV lumen (e), LV lumen (f), LV free wall (g), true RDPA (h), RDPA as would be seen
on chest x-ray (i), and true LDPA (j).
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the RDPA has been shown to be a significant predictor
for PH [18,20], as has the diastolic RV outflow tract wall
thickness [21]. In addition to this, this study novelly
found a significant difference between the PH group
and no-PH group in terms of the true RDPA diameter.
Certainly, the presence of significant abnormalities in
the measurements above ought to promptly engender
further investigation as to the presence of pulmonary
hypertension.
Modeling to control for the potential confounders
[22-24] of age, sex, AA, BSA, thoracic diameter, and
especially PWP (>15 or ≤15 mmHg) using multiple
logistic regression, showed that 10 parameters were sig-
nificant predictors of PH, despite the fact that 76% of
patients in the PH group had an elevated PWP, and
30.7% of all patients were obese (Table 6).
Beiderlinden et al, in a study of ARDS patients with at
least moderate PH (mean PA pressure of >30 mmHg),
reported a sensitivity of 54% and a specificity of 63% uti-
lizing a pulmonary artery trunk diameter ≥29 mm [25].
They also suggested that CT chest parameters were an
unreliable tool in the detection of PH in ARDS patients;
speculating that pulmonary vascular changes in chronic
rather than acute PH may lead to remodeling of the PA
and hence enlargement of its diameter. While it is diffi-
cult to ascertain the proportion of patients in the cur-
rent study with chronic PH, controlling for age, sex,
AA, BSA, thoracic diameter, and PWP category yielded
a superior sensitivity and specificity for prediction of PH
of 77.4% and 89.6%, respectively using an ULN value for
PA diameter of ≥29 mmHg.
The current study also found that an ULN cutoff of
1.29 for the main PA/DA ratio and an ULN cutoff of
>0.84 for the main PA/AA ratio could both be used to
predict PH. While this main PA/AA ratio had been
demonstrated in a previous study to strongly correlate
with mPAP in a patient population under 50 years of
age also with heterogenous diagnoses [23], a more
recent study however has suggested that the traditional
PA/AA ratio >1 is a poor diagnostic tool as it includes
normal patients and is negatively affected by age [26]. In
contrast, our study found significance using a main PA/
AA ratio of ≥0.84 or >1 in acutely ill patients even after
controlling for age in detecting the presence of PH.
Other novel predictors of PH that were found to be
significant in this study included specific cardiac mea-
surements, particularly the RV free wall of ≥6 mm, RV
lumen/LV lumen ratio ≥1.28, and RV wall/LV wall ratio
≥0.32. Of these, the RV lumen/LV lumen ratio ≥1.28
showed high sensitivity (85.7%) and specificity (86.1%,
OR = 28.8). Both the true LDPA diameter ≥21 mm and
the true RDPA diameter ≥16 mm also afforded good
sensitivities (79.2% and 83%, respectively) and high
specificities (91.7% and 87.5%, respectively), with OR’s
of 15.5 and 4.1.
An ULN cutoff of ≥6m mf o rt h eR VF r e eW a l l
showed significant promise as a predictor of PH (p =
0.0303) with a high OR of 30.5, and sensitivity of 81%
and specificity of 91.9%. It has been suggested that the
right ventricle adapts to the increased afterload in PH
by increasing muscle mass and hence wall thickness,
and by assuming a more rounded shape [27]. Other
investigators [28] studied 16 patients with primary pul-
monary hypertension and found an increase in resting
right ventricular mass. Cardiovascular Magnetic Reso-
nance Imaging may be helpful to further assess right
ventricular structure and function in PH patients [29].
PA volume estimation utilizing CT-volumetry may also
be useful in PH detection [30].
The current study has a number of limitations in part
due to its retrospective nature. Selection bias may have
been introduced by only including patients who under-
went both RHC and chest CT. Nevertheless, a consecu-
tive cohort of acutely hospitalized patients with
heterogeneous diagnoses were studied, of whom about
half had an acute primary diagnosis of CAD or CHF.
While the majority of patients in the PH group were
associated with an elevated PWP, controlling for this
using multiple logistic regression models still resulted in
statistical significance for eight pre-defined CT chest
metrics for detecting PH.
Additional limitations include the fact that some
patients underwent CT scanning breathing sponta-
neously, whilst others were on positive pressure ventila-
tion. However, this was limited to a minority of patients
(only 8.3% in the no-PH group and 15.1% in the PH
g r o u p ) .P o s i t i v ep r e s s u r ev e n t i l a t i o nm a yh a v ea f f e c t e d
end-expiratory PA diameter due to varying intrathoracic
pressures and lung volumes, affecting transmural PA
pressure. In a secondary analysis of the non-mechanically
ventilated patient cohort (n = 89), all significant findings
reported in Table 6 retained their significance, except for
three parameters (true RDPA diameter ≥16 mm, RV
wall/LV wall ratio ≥0.32, and RV lumen/LV lumen ratio
≥1.28). The loss of significance in these three parameters
is unclear, and may have been related to a smaller sample
size, a loss of power or physiological reasons.
The RHC’s and chest CT’sw e r ep e r f o r m e dam e a no f
3 days apart (median = 1 day), another limitation. It is
acknowledged that significant changes in PWP and
hence PAP can occur even on an hourly or daily basis,
depending on treatment. Nevertheless, relatively short
delays between measurements are likely to only result in
small and randomly distributed errors [25].
Standard CT window widths were used in this study,
thus minimizing variability in anatomic measurements
when compared to using non-standard window widths
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Clinician bias in measuring parameters was limited by
using separate teams, blinded to the clinical and hemo-
dynamic data, to independently review the chest CT’s.
The high incidence of CT contrast enhancement in
7 5 %o ft h en o - P Hg r o u pa n di n7 7 %o ft h eP Hg r o u p
may have aided in metric measurement. Nevertheless,
others have reported good inter-observer measurement
accuracy in a study of a heterogeneous group of patients
with PH, utilizing a mixture of enhanced and unen-
hanced CT scans of the chest [23]. Edwards et al also
demonstrated that the measurement of the pulmonary
artery diameter was extremely reproducible using unen-
hanced CT scans, with a standard deviation for the dif-
ference between 2 measurements of less than 0.08 cm
and a mean difference of only 0.02 cm [22].
Conclusions
This study has shown that there is a group of CT chest-
derived predictors of PH that shows significance, even
after controlling for age, sex, AA, BSA, thoracic dia-
meter, and especially PWP. Novel predictors including
RV free wall ≥ 6 mm, RV lumen/LV lumen ratio ≥ 1.28,
True LDPA diameter ≥ 21 mm and True RDPA dia-
meter ≥ 16 mm amongst others, may serve as a tem-
plate to detect PH in such patients with acute illnesses
requiring hospitalization and aid in determining which
patients require RHC. A confirmatory prospective multi-
centre study utilizing the significant CT chest metrics
above, and large enough to enable pre-defined subset
analysis on the various WHO Groups of PH, is needed.
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